DHR vs GMED
Danaher Corporation vs Globus Medical — AI-powered side-by-side comparison
DHR
Danaher Corporation
63
Buy
VS
GMED
Globus Medical
71
Buy
| Metric | DHR | GMED |
|---|
| AI Score |
63
|
71
|
| Price |
$204.80
|
$82.34
|
| P/E Ratio |
36.24×
|
20.74×
|
| ROE |
6.9%
|
11.8%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
58.5%
|
68.5%
|
| Debt / Equity |
0.51×
|
0.02×
|
| Dividend Yield |
0.7%
|
0.0%
|
| RSI (14) |
67.2
|
64.2
|
| Beta |
0.823
|
0.954
|
| Expected Upside |
+1.6%
|
+1.8%
|
AI Committee View
Current Innellis committee reasoning for DHR versus GMED.
GMED leads by 8 points.
GMED scores 71/100 (Buy) versus DHR at 63/100 (Buy).
DHR Committee View
80% agreement
5 analysts
The primary driver is market regime is bullish (bull market -- normal position sizing). The main limiting factor is p/e of 35.9 is moderate-to-rich. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- P/E of 35.9 is moderate-to-rich — Value
GMED Committee View
100% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is 4 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.
- Lower Highs / Lower Lows structure confirms bearish price action.